In a patient with an allergic cough, when is oral prednisone indicated and what is the recommended dose and duration?

Oral Prednisone for Allergic Cough: Indications, Dosing, and Duration

Oral prednisone is NOT indicated for typical allergic cough or allergic rhinitis, but IS indicated for severe postinfectious cough with paroxysms (30-40 mg daily for a short course) and for acute asthma exacerbations (40-60 mg daily for 5-10 days). The term "allergic cough" requires clarification of the underlying diagnosis to guide appropriate treatment.

Clinical Context and Diagnostic Clarification

The indication for oral prednisone depends critically on the specific diagnosis underlying the "allergic cough":

Postinfectious Cough with Severe Paroxysms

• For severe paroxysms of postinfectious cough, prescribe 30-40 mg of prednisone per day for a short, finite period when other common causes (upper airway cough syndrome, asthma, gastroesophageal reflux disease) have been ruled out 1.
• This represents a stepwise approach: first trial inhaled ipratropium, then inhaled corticosteroids if cough persists and affects quality of life, and reserve oral prednisone only for severe cases 1.
• Duration is typically 2-3 weeks with tapering to zero, though the evidence is from uncontrolled studies 1.
• The cough must have been present for at least 3 weeks but not more than 8 weeks following an acute respiratory infection to qualify as postinfectious 1.

Cough-Variant Asthma

• For diagnostic confirmation and initial control of cough-variant asthma, a trial of prednisone 30 mg daily establishes the diagnosis within 1-2 weeks 2, 3.
• After diagnosis is confirmed by cough resolution, transition to inhaled corticosteroids for long-term management 2.
• For acute asthma exacerbations with cough, use 40-60 mg daily in single or divided doses for 5-10 days in adults 1.
• In children, the dose is 1-2 mg/kg/day (maximum 60 mg/day) for 3-10 days 1.

Allergic Rhinitis

• Oral prednisone is NOT recommended for allergic rhinitis, as recent evidence shows no superiority over antihistamines 4.
• Intranasal corticosteroids, not oral steroids, are the mainstay of allergic rhinitis treatment 5.

Dosing Principles from FDA Labeling

General dosing ranges from 5-60 mg per day depending on disease severity, with administration in the morning prior to 9 am to minimize HPA axis suppression 6.

Key administration principles:

• Take with food or milk to reduce gastric irritation 6.
• For courses less than 1 week, no taper is needed 1.
• For courses up to 10 days, tapering is probably unnecessary if patient is on inhaled corticosteroids 1.
• Never abruptly discontinue after long-term therapy 6.

Common Pitfalls to Avoid

Critical mistake: Using oral prednisone as first-line therapy for chronic cough without establishing the underlying diagnosis 1. The stepwise approach matters:

1. First, rule out upper airway cough syndrome, asthma, and GERD 1.
2. For postinfectious cough, trial inhaled ipratropium before corticosteroids 1.
3. Reserve oral prednisone only for severe, refractory cases 1.

Second pitfall: Confusing "allergic cough" with allergic rhinitis and prescribing systemic steroids inappropriately 4. Recent evidence demonstrates that prednisolone tablets show no superiority over antihistamines for allergic rhinitis symptoms 4.

Third pitfall: Using prednisone for postinfectious cough lasting more than 8 weeks 1. At this point, consider alternative diagnoses rather than postinfectious cough 1.

Special Consideration: Allergic Bronchopulmonary Aspergillosis

For patients with ABPA (a specific allergic lung condition), use prednisolone 0.5 mg/kg/day for 2-4 weeks, then taper over 4 months total 1. This represents a distinct entity requiring longer treatment duration than typical postinfectious cough.